Helen Tremlett
Helen Tremlett
Verified email at - Homepage
Cited by
Cited by
Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity
P Browne, D Chandraratna, C Angood, H Tremlett, C Baker, BV Taylor, ...
Neurology 83 (11), 1022-1024, 2014
The prevalence of MS in the United States: a population-based estimate using health claims data
MT Wallin, WJ Culpepper, JD Campbell, LM Nelson, A Langer-Gould, ...
Neurology 92 (10), e1029-e1040, 2019
Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis
S Simpson Jr, B Taylor, L Blizzard, AL Ponsonby, F Pittas, H Tremlett, ...
Annals of neurology 68 (2), 193-203, 2010
The gut microbiome in human neurological disease: a review
H Tremlett, KC Bauer, S Appel‐Cresswell, BB Finlay, E Waubant
Annals of neurology 81 (3), 369-382, 2017
Disability progression in multiple sclerosis is slower than previously reported
H Tremlett, D Paty, V Devonshire
Neurology 66 (2), 172-177, 2006
New perspectives in the natural history of multiple sclerosis
H Tremlett, Y Zhao, P Rieckmann, M Hutchinson
Neurology 74 (24), 2004-2015, 2010
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis
A Shirani, Y Zhao, ME Karim, C Evans, E Kingwell, ML Van Der Kop, ...
Jama 308 (3), 247-256, 2012
Gut microbiota in early pediatric multiple sclerosis: a case− control study
H Tremlett, DW Fadrosh, AA Faruqi, F Zhu, J Hart, S Roalstad, J Graves, ...
European journal of neurology 23 (8), 1308-1321, 2016
Relapses in multiple sclerosis are age-and time-dependent
H Tremlett, Y Zhao, J Joseph, V Devonshire
Journal of neurology, Neurosurgery & psychiatry 79 (12), 1368-1374, 2008
Interrupted therapy: stopping and switching of the β-interferons prescribed for MS
HL Tremlett, J Oger
Neurology 61 (4), 551-554, 2003
Natural history of secondary-progressive multiple sclerosis
H Tremlett, Y Zhao, V Devonshire
Multiple Sclerosis Journal 14 (3), 314-324, 2008
Impact of multiple sclerosis relapses on progression diminishes with time
H Tremlett, M Yousefi, V Devonshire, P Rieckmann, Y Zhao
Neurology 73 (20), 1616-1623, 2009
The natural history of secondary progressive multiple sclerosis
M Koch, E Kingwell, P Rieckmann, H Tremlett
Journal of Neurology, Neurosurgery & Psychiatry 81 (9), 1039-1043, 2010
The natural history of primary progressive multiple sclerosis
M Koch, E Kingwell, P Rieckmann, H Tremlett
Neurology 73 (23), 1996-2002, 2009
Health-related quality of life in multiple sclerosis: direct and indirect effects of comorbidity
LI Berrigan, JD Fisk, SB Patten, H Tremlett, C Wolfson, S Warren, KM Fiest, ...
Neurology 86 (15), 1417-1424, 2016
Longitudinal follow-up of “benign” multiple sclerosis at 20 years
AL Sayao, V Devonshire, H Tremlett
Neurology 68 (7), 496-500, 2007
Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada
E Kingwell, M Van der Kop, Y Zhao, A Shirani, F Zhu, J Oger, H Tremlett
Journal of Neurology, Neurosurgery & Psychiatry 83 (1), 61-66, 2012
Monthly ambient sunlight, infections and relapse rates in multiple sclerosis
H Tremlett, IAF Van Der Mei, F Pittas, L Blizzard, G Paley, D Mesaros, ...
Neuroepidemiology 31 (4), 271-279, 2008
Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review
E Lu, BW Wang, C Guimond, A Synnes, D Sadovnick, H Tremlett
Neurology 79 (11), 1130-1135, 2012
Psychiatric comorbidity is associated with disability progression in multiple sclerosis
KA McKay, H Tremlett, JD Fisk, T Zhang, SB Patten, L Kastrukoff, ...
Neurology 90 (15), e1316-e1323, 2018
The system can't perform the operation now. Try again later.
Articles 1–20